Rockefeller Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-572
| Closed | -$38K | – | 3054 |
|
|
2022
Q4 | $38K | Sell |
572
-345
| -38% | -$22.9K | ﹤0.01% | 2514 |
|
|
2022
Q3 | $49K | Buy |
917
+558
| +155% | +$29.8K | ﹤0.01% | 2355 |
|
|
2022
Q2 | $19K | Hold |
359
| – | – | ﹤0.01% | 2777 |
|
|
2022
Q1 | $25K | Sell |
359
-119
| -25% | -$8.29K | ﹤0.01% | 2623 |
|
|
2021
Q4 | $46K | Buy |
478
+157
| +49% | +$15.1K | ﹤0.01% | 2259 |
|
|
2021
Q3 | $27K | Sell |
321
-113
| -26% | -$9.51K | ﹤0.01% | 2455 |
|
|
2021
Q2 | $35K | Hold |
434
| – | – | ﹤0.01% | 2238 |
|
|
2021
Q1 | $40K | Hold |
434
| – | – | ﹤0.01% | 1982 |
|
|
2020
Q4 | $26K | Buy |
434
+121
| +39% | +$7.25K | ﹤0.01% | 1902 |
|
|
2020
Q3 | $17K | Buy |
313
+162
| +107% | +$8.8K | ﹤0.01% | 1849 |
|
|
2020
Q2 | $11K | Sell |
151
-53
| -26% | -$3.86K | ﹤0.01% | 1863 |
|
|
2020
Q1 | $9K | Buy |
204
+188
| +1,175% | +$8.29K | ﹤0.01% | 1775 |
|
|
2019
Q4 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1986 |
|
|
2019
Q2 | – | Sell |
-341
| Closed | -$27K | – | 1825 |
|
|
2019
Q1 | $27K | Buy |
341
+254
| +292% | +$20.1K | ﹤0.01% | 1124 |
|
|
2018
Q4 | $7K | Hold |
87
| – | – | ﹤0.01% | 760 |
|
|
2018
Q3 | $15K | Hold |
87
| – | – | ﹤0.01% | 534 |
|
|
2018
Q2 | $11K | Buy |
+87
| New | +$11K | ﹤0.01% | 586 |
|